Sector: Health Care
Director information for AVANTOR INC (data for year 2026)
| Name | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| Dame Louise Makin | Chair, Halma plc; Non-Executive Chair of the Halma Plc Board of Directors | 65 | ["Chief Executive Officer at BTG Plc (2004-2019)", "President of Biopharmaceuticals Europe at Baxter Healthcare (2000-2004)", "Honorary Fellow at St. John\u2019s College, Cambridge (2015-present)", "Master\u2019s Degree in Natural Sciences and a Ph.D. in Material Sciences from the University of Cambridge", "MBA from The Open University in Milton Keynes, England"] | ["Audit & Finance", "Nominating & Governance"] | 2026 |
| Emmanuel Ligner | President and Chief Executive Officer, Avantor, Inc. | 55 | ["Over 30 years of strategic and operational leadership experience at large-scale, global, life sciences companies", "CEO of Avantor, providing understanding of global operations and commercial strategy"] | [] | 2026 |
| Gregory Lucier | Founder, Executive Chairman and CEO of Corza Medical | 61 | ["Founder of Corza Medical", "Former CEO and Chairman of NuVasive", "Former Chairman and CEO of Life Technologies Corporation", "Former President of Medical Information Technologies at GE Healthcare", "MBA from Harvard Business School", "Bachelor\u2019s Degree in Industrial Engineering from Pennsylvania State University", "Over 30 years of life sciences industry experience"] | ["Compensation & Human Resources", "Nominating & Governance (Chair)", "Nominating & Governance"] | 2026 |
| Gregory Summe | Managing Partner, GlenCapital Partners; Chairman | 68 | ["Founder and Managing Partner of Glen Capital Partners", "Founder and Managing Partner of Star Mountain Capital", "Senior Advisor of NextGen Acquisition Corp I & II", "Co-founder of The Carlyle Group", "Managing Director and Vice Chairman of Global Buyout at Goldman Sachs Capital Partners", "Senior Advisor at PerkinElmer", "Chairman and Chief Executive Officer at AlliedSignal", "President of General Aviation Avionics", "President of the Aerospace Engines Group", "President of the Automotive Products Group at McKinsey & Co.", "MBA with distinction from The Wharton School of the University of Pennsylvania", "Master\u2019s Degree in Electrical Engineering from University of Cincinnati", "Bachelor\u2019s Degree in Electrical Engineering from University of Kentucky"] | ["Compensation & Human Resources", "Nominating & Governance"] | 2026 |
| Joseph Massaro | Vice Chair and President, Engineered Components, Aptiv PLC | 56 | ["Senior leadership experience as a chief financial officer", "Expertise in international business transactions", "Expertise in information technology and systems management", "Expertise in strategy and financial accounting", "Qualification as an audit committee financial expert"] | ["Audit & Finance (Chair)", "Nominating & Governance", "Audit & Finance"] | 2026 |
| Mala Murthy | Chief Financial Officer, TriNet Group, Inc. | 62 | ["Chief Financial Officer for TriNet Group, Inc.", "Chief Financial Officer at Teladoc Health, Inc.", "Chief Financial Officer at American Express", "Chief Financial Officer of the Global Commercial Services segment at PepsiCo", "Various leadership positions, leading high growth business units", "MBA from the India Institute of Management", "Master\u2019s Degree in Public and Private Management from Yale School of Management", "Bachelor\u2019s Degree in Computer Science and Engineering from Jadavpur University in India", "Expertise in international business transactions, information technology and systems management, financial accounting and strategic growth", "Qualification as an audit committee financial expert"] | ["Audit & Finance"] | 2026 |
| Michael Severino, M.D. | Chief Executive Officer, Tessera Therapeutics | 60 | ["Chief Executive Officer of Tessera Therapeutics, Inc.", "Vice Chairman and President at AbbVie Inc.", "Executive Vice President, Research & Development at AbbVie Inc.", "Chief Scientific Officer at AbbVie Inc.", "Senior Vice President, Global Development at Amgen, Inc.", "Chief Medical Officer at Amgen, Inc.", "M.D. from Johns Hopkins University", "Residency and Fellowship Training at Massachusetts General Hospital and Harvard Medical School", "Bachelor\u2019s Degree in Biochemistry from the University of Maryland"] | ["Compensation & Human Resources (Chair)", "Science & Technology", "Compensation & Human Resources"] | 2026 |
| Sanjeev Mehra | Co-Founder and Managing Partner of Periphas Capital LP | 67 | ["Co-Founder and Managing Partner of Periphas Capital LP", "Vice Chairman of the Global Private Equity business at Goldman Sachs", "Co-Head of US Private Equity at Goldman Sachs", "Partner at Goldman Sachs", "Founding Member of Principal Investment Area at Goldman Sachs", "MBA from Harvard Business School", "Bachelor\u2019s Degree in Economics from Harvard College", "Extensive leadership experience at Goldman Sachs", "Board and advisory experience across multiple industries", "Experience in capital allocation, finance, strategy and international business transactions"] | ["Audit & Finance", "Compensation & Human Resources"] | 2026 |
| Simon Dingemans | Former Chief Financial Officer of GlaxoSmithKline plc; Director | 62 | ["Former Chief Financial Officer at GlaxoSmithKline plc", "Managing Director and Senior Advisor at The Carlyle Group", "Chief Financial Officer at GlaxoSmithKline plc", "Partner and Managing Director at Goldman Sachs International", "Master\u2019s Degree in Geography from University of Oxford", "Extensive leadership experience across global healthcare and financial institutions", "Experience in finance, strategy, capital allocation and organizational transformation", "Qualification as an audit committee financial expert"] | ["Audit & Finance"] | 2026 |
